Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Cipla launches ViraGen, a COVID-19 RT-PCR test
Cipla will commence supply of ViraGen, its third offering in the COVID-19 testing segment, from May 25, 2021
Global diabetes therapeutic market has grown sixfold in last two decades: GlobalData
The market has been a lucrative space for drug developers, as the disease is highly prevalent and patient numbers are expected to…
ISCR lauds clinical research stakeholders on International Clinical Trials Day
New models of clinical trials were effectively developed to ensure continuity of trials in a pandemic environment without…
Optimus Pharma gets DCGI nod for Phase III trials of Molnupiravir for COVID-19 treatment
As per the clinical trial protocol approved, 2500 subjects with mild to moderate COVID-19 will be randomised in the study in a 1:1…
Goldman Sachs invests in Aragen Life Sciences
These shares were previously held by ChrysCapital and other existing shareholders
BDR Pharma signs voluntary licensing agreement with Lilly for baricitinib
Lilly had recently announced seven other voluntary license agreements with major drug manufacturers in India for the production of…
Anupam Rasayan receives Rs 540 crore order from two MNCs dealing in life sciences chemicals
The tenure of the contract is for five years
Spanish study finds AstraZeneca vaccine followed by Pfizer dose is safe and effective
The presence of neutralising antibodies rose sevenfold after a Pfizer dose, significantly more than the doubling effect observed…
American civil rights leader to request US President to release 60 million COVID-19 vaccine doses to…
Rev. Jackson will be joined by a number of prominent Indian leaders in Washington to make a public appeal to Biden for more…
More pharma companies should be permitted to produce COVID-19 vaccines: Gadkari
Instead of one company, 10 more companies should be allowed to make vaccines by paying 10 per cent royalty to the original patent…